Your browser doesn't support javascript.
loading
Preferential Gs protein coupling of the galanin Gal1 receptor in the µ-opioid-Gal1 receptor heterotetramer.
De Oliveira, Paulo A; Moreno, Estefanía; Casajuana-Martin, Nil; Casadó-Anguera, Verònica; Cai, Ning-Sheng; Camacho-Hernandez, Gisela Andrea; Zhu, Hu; Bonifazi, Alessandro; Hall, Matthew D; Weinshenker, David; Newman, Amy Hauck; Logothetis, Diomedes E; Casadó, Vicent; Plant, Leigh D; Pardo, Leonardo; Ferré, Sergi.
Afiliação
  • De Oliveira PA; Integrative Neurobiology Section, USA.
  • Moreno E; Laboratory of Molecular Neuropharmacology, Department of Biochemistry and Molecular Biomedicine, Faculty of Biology and Institute of Biomedicine, University of Barcelona, Barcelona, Spain.
  • Casajuana-Martin N; Laboratory of Computational Medicine, Biostatistics Unit, Faculty of Medicine, Autonomous University of Barcelona, Bellaterra, Spain.
  • Casadó-Anguera V; Laboratory of Molecular Neuropharmacology, Department of Biochemistry and Molecular Biomedicine, Faculty of Biology and Institute of Biomedicine, University of Barcelona, Barcelona, Spain.
  • Cai NS; Integrative Neurobiology Section, USA.
  • Camacho-Hernandez GA; Medicinal Chemistry Section, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD, USA.
  • Zhu H; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA.
  • Bonifazi A; Medicinal Chemistry Section, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD, USA.
  • Hall MD; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA.
  • Weinshenker D; Department of Human Genetics, Emory University School of Medicine, Atlanta, GA, USA.
  • Newman AH; Medicinal Chemistry Section, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD, USA.
  • Logothetis DE; Departments of Pharmaceutical Sciences, Chemistry and Chemical Biology and Center for Drug Discovery, School of Pharmacy at the Bouvé College of Health Sciences and College of Science, Northeastern University, Boston, MA, USA.
  • Casadó V; Laboratory of Molecular Neuropharmacology, Department of Biochemistry and Molecular Biomedicine, Faculty of Biology and Institute of Biomedicine, University of Barcelona, Barcelona, Spain. Electronic address: vcasado@ub.edu.
  • Plant LD; Departments of Pharmaceutical Sciences, Chemistry and Chemical Biology and Center for Drug Discovery, School of Pharmacy at the Bouvé College of Health Sciences and College of Science, Northeastern University, Boston, MA, USA. Electronic address: l.plant@northeastern.edu.
  • Pardo L; Laboratory of Computational Medicine, Biostatistics Unit, Faculty of Medicine, Autonomous University of Barcelona, Bellaterra, Spain. Electronic address: Leonardo.Pardo@uab.cat.
  • Ferré S; Integrative Neurobiology Section, USA. Electronic address: sferre@intra.nida.nih.gov.
Pharmacol Res ; 182: 106322, 2022 08.
Article em En | MEDLINE | ID: mdl-35750299
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Galanina / Analgésicos Opioides Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Galanina / Analgésicos Opioides Idioma: En Ano de publicação: 2022 Tipo de documento: Article